SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285793869> ?p ?o ?g. }

Showing items 1 to 100 of ±166 with 100 items per page.

W4285793869 abstract "Vaccine development is essential for pandemic preparedness. We previously conducted a Phase 1 clinical trial of the vector vaccine candidate MVA-MERS-S against the Middle East respiratory syndrome coronavirus (MERS-CoV), expressing its full spike glycoprotein (MERS-CoV-S), as a homologous two-dose regimen (Days 0 and 28). Here, we evaluate the safety (primary objective) and immunogenicity (secondary and exploratory objectives: magnitude and characterization of vaccine-induced humoral responses) of a third vaccination with MVA-MERS-S in a subgroup of trial participants one year after primary immunization. MVA-MERS-S booster vaccination is safe and well-tolerated. Both binding and neutralizing anti-MERS-CoV antibody titers increase substantially in all participants and exceed maximum titers observed after primary immunization more than 10-fold. We identify four immunogenic IgG epitopes, located in the receptor-binding domain (RBD, n = 1) and the S2 subunit (n = 3) of MERS-CoV-S. The level of baseline anti-human coronavirus antibody titers does not impact the generation of anti-MERS-CoV antibody responses. Our data support the rationale of a booster vaccination with MVA-MERS-S and encourage further investigation in larger trials. Trial registration: Clinicaltrials.gov NCT03615911." @default.
W4285793869 created "2022-07-19" @default.
W4285793869 creator A5003451290 @default.
W4285793869 creator A5004691327 @default.
W4285793869 creator A5009334726 @default.
W4285793869 creator A5012755708 @default.
W4285793869 creator A5013117972 @default.
W4285793869 creator A5014344158 @default.
W4285793869 creator A5022565590 @default.
W4285793869 creator A5024071137 @default.
W4285793869 creator A5036222002 @default.
W4285793869 creator A5037436749 @default.
W4285793869 creator A5041846756 @default.
W4285793869 creator A5043617981 @default.
W4285793869 creator A5044802324 @default.
W4285793869 creator A5049816265 @default.
W4285793869 creator A5051577519 @default.
W4285793869 creator A5052831370 @default.
W4285793869 creator A5052849693 @default.
W4285793869 creator A5054424705 @default.
W4285793869 creator A5055394085 @default.
W4285793869 creator A5061458555 @default.
W4285793869 creator A5062147169 @default.
W4285793869 creator A5065775733 @default.
W4285793869 creator A5070000278 @default.
W4285793869 creator A5073782617 @default.
W4285793869 creator A5077285679 @default.
W4285793869 creator A5083282370 @default.
W4285793869 creator A5084289126 @default.
W4285793869 date "2022-07-19" @default.
W4285793869 modified "2023-10-15" @default.
W4285793869 title "Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome" @default.
W4285793869 cites W1136695336 @default.
W4285793869 cites W1852588318 @default.
W4285793869 cites W2065411691 @default.
W4285793869 cites W2103807321 @default.
W4285793869 cites W2105558257 @default.
W4285793869 cites W2108756402 @default.
W4285793869 cites W2116736752 @default.
W4285793869 cites W2161687688 @default.
W4285793869 cites W2270879391 @default.
W4285793869 cites W2282108752 @default.
W4285793869 cites W2344740792 @default.
W4285793869 cites W2765158823 @default.
W4285793869 cites W2766598255 @default.
W4285793869 cites W2790876064 @default.
W4285793869 cites W2803286407 @default.
W4285793869 cites W2932403381 @default.
W4285793869 cites W2963951165 @default.
W4285793869 cites W2966260934 @default.
W4285793869 cites W2968573498 @default.
W4285793869 cites W3011746195 @default.
W4285793869 cites W3016653642 @default.
W4285793869 cites W3017390697 @default.
W4285793869 cites W3031830637 @default.
W4285793869 cites W3087903445 @default.
W4285793869 cites W3087924281 @default.
W4285793869 cites W3093040616 @default.
W4285793869 cites W3120033778 @default.
W4285793869 cites W3127836986 @default.
W4285793869 cites W3136693147 @default.
W4285793869 cites W3148143574 @default.
W4285793869 cites W3175923549 @default.
W4285793869 cites W3190427561 @default.
W4285793869 cites W3200511289 @default.
W4285793869 cites W3208073486 @default.
W4285793869 cites W4200177230 @default.
W4285793869 cites W4200585097 @default.
W4285793869 cites W4210450230 @default.
W4285793869 cites W4236514778 @default.
W4285793869 cites W96198987 @default.
W4285793869 doi "https://doi.org/10.1038/s41467-022-31557-0" @default.
W4285793869 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35853863" @default.
W4285793869 hasPublicationYear "2022" @default.
W4285793869 type Work @default.
W4285793869 citedByCount "5" @default.
W4285793869 countsByYear W42857938692022 @default.
W4285793869 countsByYear W42857938692023 @default.
W4285793869 crossrefType "journal-article" @default.
W4285793869 hasAuthorship W4285793869A5003451290 @default.
W4285793869 hasAuthorship W4285793869A5004691327 @default.
W4285793869 hasAuthorship W4285793869A5009334726 @default.
W4285793869 hasAuthorship W4285793869A5012755708 @default.
W4285793869 hasAuthorship W4285793869A5013117972 @default.
W4285793869 hasAuthorship W4285793869A5014344158 @default.
W4285793869 hasAuthorship W4285793869A5022565590 @default.
W4285793869 hasAuthorship W4285793869A5024071137 @default.
W4285793869 hasAuthorship W4285793869A5036222002 @default.
W4285793869 hasAuthorship W4285793869A5037436749 @default.
W4285793869 hasAuthorship W4285793869A5041846756 @default.
W4285793869 hasAuthorship W4285793869A5043617981 @default.
W4285793869 hasAuthorship W4285793869A5044802324 @default.
W4285793869 hasAuthorship W4285793869A5049816265 @default.
W4285793869 hasAuthorship W4285793869A5051577519 @default.
W4285793869 hasAuthorship W4285793869A5052831370 @default.
W4285793869 hasAuthorship W4285793869A5052849693 @default.
W4285793869 hasAuthorship W4285793869A5054424705 @default.
W4285793869 hasAuthorship W4285793869A5055394085 @default.
W4285793869 hasAuthorship W4285793869A5061458555 @default.
W4285793869 hasAuthorship W4285793869A5062147169 @default.